PRIG
CVS icon

Payden & Rygel Investment Group’s CVS Health CVS Stock Holding History

Payden & Rygel Investment Group’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-183,500
Closed -$14.6M – 127
2024
Q1 		$14.6M Buy
+183,500
New +$14M 0.69% 57
2023
Q3 		$19.8M Buy
+283,400
New +$20.1M 1.35% 16

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Payden & Rygel Investment Group's CVS Position: Q2 2024 in Review

Payden & Rygel Investment Group sold out of CVS Health (CVS) in Q2 2024, closing a stake of 183,500 shares — an estimated $14.6M sold.

Payden & Rygel Investment Group first reported a position in CVS in Q3 2023 and held it in 2 quarters. The position peaked at $19.8M in Q3 2023. 1,910 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • Payden & Rygel Investment Group reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • Payden & Rygel Investment Group sold 183,500 CVS Health shares in Q2 2024, an estimated $14.6M.
  • Payden & Rygel Investment Group first reported a position in CVS Health in Q3 2023 and held it in 2 quarters.
  • Payden & Rygel Investment Group's CVS Health position peaked at $19.8M in Q3 2023.
  • 1,910 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.